About This Study
The purpose of this study is to learn more about treating low-grade gliomas. We want to find the highest dose of Vinblastine that can be given safely along with Selumetinib. We also want to find out if Selumetinib and Vinblastine combined work better than Selumetinib alone. Studies like this can help improve treatment and quality of life.
Need volunteers diagnosed with low-grade glioma that has been difficult to treat or returned after treatment. Taking part in this study will last about two years. Study team will discuss study details with you.
What Activities Are a Part of this Study?
- Informed Consent Review
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
Age & Gender
- 2 - 25 years old
- All Genders
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- No reimbursement offered
Study Locations
- Greater Winston-Salem, NC